Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2012 by Stanford University.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Genentech
Information provided by (Responsible Party):
Pamela L. Kunz, Stanford University
ClinicalTrials.gov Identifier:
NCT00780494
First received: October 23, 2008
Last updated: September 3, 2012
Last verified: September 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2014
  Estimated Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)